Aitiabio
1 known investors
Aitia builds in silico models of human disease biology using a causal AI platform that combines multiomic and clinical patient data with supercomputing to support drug discovery and development. It partners with biopharma companies to identify novel drug targets across diseases such as oncological, neurodegenerative, immunological, and cardiometabolic conditions.
Investors · 1
Frequently asked questions
- What does Aitiabio do?
- Aitia builds in silico models of human disease biology using a causal AI platform that combines multiomic and clinical patient data with supercomputing to support drug discovery and development. It partners with biopharma companies to identify novel drug targets across diseases such as oncological, neurodegenerative, immunological, and cardiometabolic conditions.
- Who are Aitiabio's investors?
- Aitiabio's investors include Echo Health Ventures.